0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Cellular biology

Buy Now

D-type Cyclins and Cancer (Hardcover, 1st ed. 2018) Loot Price: R3,370
Discovery Miles 33 700
You Save: R577 (15%)
D-type Cyclins and Cancer (Hardcover, 1st ed. 2018): Philip W. Hinds, Nelson E. Brown

D-type Cyclins and Cancer (Hardcover, 1st ed. 2018)

Philip W. Hinds, Nelson E. Brown

Series: Current Cancer Research

 (sign in to rate)
List price R3,947 Loot Price R3,370 Discovery Miles 33 700 | Repayment Terms: R316 pm x 12* You Save R577 (15%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This volume provides an integrated account of our current understanding of the functions of D-type cyclins during development and tumorigenesis, with special emphasis on the kinase-independent functions of these proteins. The volume will provide a thorough review of the latest discoveries on the new functions and interacting partners of mammalian cyclin Ds crucial to explain their oncogenic and differentiation properties in different cellular contexts. The volume begins with a historical perspective of how D-type cyclins were first discovered and eventually cloned from cancer tissues, followed by an account on the canonical functions of cyclin Ds during the G1-S transition of the cell cycle. Several chapters will be devoted to review the functions of D-type cyclins as transcriptional regulators and the mechanisms through which these novel functions could impact the tumorigenic process. Also discussed is emerging evidence that points to a role of D-type cyclins, particularly cyclin D1, as a cytoplasmic regulator of various cellular functions. This property, in human cells at least, is traceable to certain splice isoforms with novel oncogenic implications. Finally, a chapter is devoted to recent efforts to revise the canonical view of the "retinoblastoma pathway" to incorporate new evidence that suggests that cyclin D1's role in G1 is to singly-phosphorylate the retinoblastoma protein (pRb) for discrimination of target protein interactions. This work represents a significant departure from the view of cyclin D1 as a negative regulator of pRb and may have critical implications for understanding the function of antineoplastic agents that target the cyclin D1-associated kinases.

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Current Cancer Research
Release date: October 2017
First published: 2018
Editors: Philip W. Hinds • Nelson E. Brown
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 152
Edition: 1st ed. 2018
ISBN-13: 978-3-319-64449-3
Categories: Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Science & Mathematics > Biology, life sciences > Cellular biology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 3-319-64449-1
Barcode: 9783319644493

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners